Why Is Zarontin So Hard to Find? [Explained for 2026]

You've been taking Zarontin for absence seizures—maybe for years. Then one day your pharmacy tells you they're out of stock. You call the next pharmacy. Same answer. What is going on?

Zarontin (ethosuximide) is a critical medication for people with absence epilepsy. But in 2026, finding it at your local pharmacy can feel like a scavenger hunt. This post explains exactly why that happens—and what practical steps you can take today.

What Is Zarontin and Why Do People Need It?

Zarontin is the brand name for ethosuximide, an anticonvulsant in the succinimide drug class. It has been FDA-approved since the 1960s for the treatment of absence seizures—brief lapses in consciousness sometimes called "staring spells" or petit mal seizures—in patients aged 3 and older.

A landmark randomized controlled trial published in the New England Journal of Medicine confirmed that ethosuximide is the optimal first-line monotherapy for childhood absence epilepsy, achieving seizure freedom in roughly 45% of children at 12 months with a favorable side effect profile compared to alternatives. For many patients, there is simply no equivalent substitute.

Is Zarontin in an Official Shortage in 2026?

As of early 2026, Zarontin (ethosuximide) is not listed on the FDA or ASHP drug shortage databases. But that doesn't mean it's easy to find. Many patients report significant difficulty filling their prescriptions even when no formal shortage exists. Here's why.

Why Is Zarontin So Hard to Find at Pharmacies?

Several structural factors make Zarontin harder to find than most common medications:

1. It Serves a Small Patient Population

Absence seizures are most common in children and affect a relatively small percentage of the overall population. Ethosuximide is used almost exclusively for this one seizure type. Unlike blockbuster drugs that millions of people take every day, Zarontin's patient population is niche. Large chain pharmacies stock medications based on demand, and many simply don't bother keeping ethosuximide on their shelves.

2. Very Few Manufacturers Make It

Pfizer manufactures the brand-name Zarontin oral solution, and only a small number of companies produce generic ethosuximide capsules. With so few producers, any disruption in manufacturing—a factory issue, raw material shortage, or regulatory delay—can create ripple effects across the entire country's supply.

3. Wholesaler Allocation Prioritizes High-Volume Accounts

When supply is constrained, drug wholesalers allocate available stock to their highest-volume pharmacy customers first. This can leave smaller independent pharmacies—which are often more willing to special-order Zarontin—waiting weeks for their shipments. Even if ethosuximide is technically available nationally, regional gaps are common.

4. Cost Can Be a Barrier Even When Supply Is Available

The cash price for Zarontin without insurance ranges from about $200 to $580 for a 30-day supply. Brand-name Zarontin oral solution can be as high as $579.83 at retail. However, discount cards like GoodRx can reduce the cost to as low as $33.61 for generic ethosuximide—an 84% discount off retail price.

What Can You Do Right Now If You Can't Find Zarontin?

Here are your best options if your pharmacy doesn't have Zarontin in stock:

• Try both formulations. Zarontin comes as 250 mg capsules and as a 250 mg/5 mL oral solution. If one formulation is out of stock, the other may be available. Ask your prescriber if switching is appropriate.
• Call independent pharmacies. Independent pharmacies are more likely to order specialty or niche medications than large chains. They may also have existing supplier relationships that help.
• Use medfinder. medfinder.com calls pharmacies near you to find which ones can fill your Zarontin prescription—saving you hours of calling around yourself.
• Refill early. If you know Zarontin can be hard to find, try to request a refill one to two weeks before you run out. This gives your pharmacy extra time to source it.
• Consider mail-order pharmacy. Some mail-order pharmacies stock niche anticonvulsants more reliably. Check with your insurance plan's preferred mail-order option.
• Talk to your neurologist about alternatives. If Zarontin remains unavailable, valproic acid (Depakote) or lamotrigine (Lamictal) may be appropriate temporary alternatives. Never stop taking Zarontin abruptly—this can trigger absence status epilepticus.

Never Stop Zarontin Without Talking to Your Doctor First

This is critically important: do not stop taking ethosuximide suddenly. Abrupt discontinuation of any antiseizure medication can trigger breakthrough seizures, including absence status epilepticus. If you are running low and cannot find a refill, contact your neurologist immediately to discuss a plan.

How Much Does Zarontin Cost Without Insurance?

Without insurance, Zarontin can cost between $200 and $580 for a 30-day supply, depending on the formulation and pharmacy. With GoodRx, generic ethosuximide can drop to as low as $33.61. SingleCare offers prices around $35.88. For a detailed savings guide, read our post on how to save money on Zarontin in 2026.

The Bottom Line

Zarontin (ethosuximide) is not in a formal FDA shortage as of 2026, but its niche market, limited manufacturers, and low-stocking rates at pharmacies create real access challenges for patients. The best strategy is to plan ahead, explore both formulations, and use tools like medfinder to find pharmacies with stock near you. For more, see our detailed Zarontin shortage update for 2026.